ONKURE THERAPEUTICS, INC. (OKUR) Return on equity
ONKURE THERAPEUTICS, INC. (OKUR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-50.7%FY2024
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -50.7% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More OKUR financial trends
OKUR RevenueOKUR Net incomeOKUR Net marginOKUR Gross profitOKUR Gross marginOKUR Operating incomeOKUR Operating marginOKUR Operating cash flowOKUR Free cash flowOKUR Capital expendituresOKUR Stock buybacksOKUR Dividends paidOKUR Total assetsOKUR Total liabilitiesOKUR Shareholders’ equityOKUR overview →